Navigation Links
ICUROS study finds international variations in quality of life loss after fracture
Date:3/24/2011

A study presented today at the European Congress on Osteoporosis and Osteoarthritis currently taking place in Valencia, Spain has found that the initial quality of life loss following an osteoporotic fracture is substantial, especially with regard to hip and vertebral fractures. The study found differences in quality of life loss between countries after correcting for other explanatory variables.

The quality of life (QoL) of patients who sustained a hip, wrist or vertebral fracture was examined for the four months following the fracture. The study is part of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS) which is an international patient-based study endorsed by the International Osteoporosis Foundation. ICUROS investigates the costs and health effects of osteoporotic fractures in women and men over the age of fifty. The aim is to gather better information regarding the burden of osteoporosis in the participating countries and worldwide. Currently, eleven countries are involved in ICUROS.

Involving 2,737 patients from nine countries, the study found that quality of life loss over four months was highest for hip fractures, followed by vertebral and wrist fractures. Interestingly, significant variations between countries were identified. Quality of life loss after hip fracture was greatest in Lithuania, followed by Italy, Russia and Mexico. Lower quality of life loss was experienced by hip fracture patients in Austria and Sweden. In all countries in which vertebral fractures were studied, patients who were hospitalized experienced more quality of life loss than those who were not hospitalized following vertebral fracture.


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. Children With Tourette Syndrome Have Better Motor Control, Study Finds
2. Americans Exposure to Mercury From Fish Wont Harm Hearts: Study
3. Even Mild Stress Can Lead to Disability, Study Says
4. Actos Cut Risk of Prediabetes Becoming Diabetes in Study
5. Menthol Cigarettes Pose No Added Lung Cancer Risk: Study
6. Mass. General study reveals how lung cancers evolve in response to targeted treatment
7. Sleep Less, Eat More: Study
8. Lung Cancer Evolves With Treatment, Study Finds
9. Long-term study: Robot-assisted prostate surgery is safe
10. Study: Infrequent Sex Can Raise Risk of Heart Attack, Death
11. UT MD Anderson receives grant for study of acupuncture in cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... 2017 , ... Salveo for life, a company that distributes an effervescent lime-flavored ... States as part of its presence to expand its market reach. , Using a ... productions of nasty toxins as a result of drinking alcohol, eliminating those toxins quickly, ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Seamild, the ... on the futuristic vision of its owner and founder. As Oat is recognized globally ... to everybody he knows personally as he believes it is a move to sow ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... ... of Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual ... alumni, family, friends, and community. “Coming Home 2017” will be held on ...
(Date:1/21/2017)... Santa Rosa, CA (PRWEB) , ... January 21, ... ... announce the opening of its new medical office in Petaluma, located at 167 ... full-service casting room, access to SRO sports medicine and rehabilitation services ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... Texas Periodontist Dr. Dan Holtzclaw in media for its creos™ line of bone ... performed by Dr. Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... , Jan. 20, 2017  Palladian Health, ... has announced the launch of an opioid management ... guidelines on opioids and helps stem the growing ... often prescribed to treat chronic non-cancer pain (back ... serious risks and lack of evidence regarding long-term ...
(Date:1/19/2017)... 2017 The global immunomodulators market is ... according to a new study by Grand View ... predominantly driven by high R&D investments employed by ... of new and therapeutically advanced drugs. This is ... an unprecedented rate into the immunomodulators market hence ...
(Date:1/19/2017)... 19, 2017 Report Details ... Alzheimer,s Disease ... Companies – our new study reveals trends, R&D progress, ... events affecting the Alzheimer,s disease therapeutics and diagnostics market. ... key questions: - How is the Alzheimer,s disease therapeutics ...
Breaking Medicine Technology: